Andy Pasternak has sold HZNP and made no open-market buys since Sep 2021
EVP and Chief Strategy Officer at Horizon Therapeutics Public Ltd Co
SEC CIK 0001792746 · Filings on SEC.gov ↗
$0Bought
$13.8MSold
NoneLast buy
Every filing
8 filings since Sep 2021, newest first
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and Chief Strategy Officer
$3.1M−33.0%Jan 18
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and Chief Strategy Officer
$3.4M−47.0%Dec 14
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and Chief Business Officer
$400K−12.0%Jul 29
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and Chief Business Officer
$65K−2.0%Jun 13
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and Chief Business Officer
$124K−3.0%Feb 18
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and Chief Business Officer
$795K−16.0%Jan 6
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and Chief Business Officer
$3.4M−56.0%Nov 5
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and Chief Business Officer
$2.5M−50.0%Sep 13
Filings come from SEC EDGAR. Not investment advice.